WallStreetZenWallStreetZen

AnalystsRobert Burns
Robert Burns's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4425 out of 4426 analysts
Average Return
-20.62%
Win Rate
29%73 out of 256
Risk vs Reward
Poor
Good

Robert Burns's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Immunomedics IncIMMU
+342.36%$18.91$83.65
2020-04-07 -
2020-09-14
Buy
Turning Point Therapeutics IncTPTX
+208.74%$35.13$108.46
2020-03-17 -
2021-03-17
Buy
Immunomedics IncIMMU
+158.98%$32.30$83.65
2020-05-07 -
2020-09-14
Buy
Turning Point Therapeutics IncTPTX
+153.91%$29.44$74.75
2022-03-22 -
2022-06-06
Buy
Tango Therapeutics IncTNGX
+144.15%$3.76$9.18
2023-03-28 -
2023-12-08
Buy

Robert Burns Analyst Color

Get additional color on Robert Burns's coverage of popular stocks

Robert Burns's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Igm Biosciences IncIGMS
9Hold$7.00+5.26%Downgrades
3 days ago
Portage Biotech IncPRTG
5Buy$6.00+426.32%Maintains
11 days ago
Springworks Therapeutics IncSWTX
19Buy$73.00+131.75%Maintains
11 days ago
Biontech SeBNTX
19Buy$133.00+28.59%Reiterates
13 days ago
Kronos Bio IncKRON
6Buy$9.00+538.30%Reiterates
13 days ago
Calidi Biotherapeutics IncCLDI
1Buy$11.00+416.43%Initiates Coverage On
18 days ago
Black Diamond Therapeutics IncBDTX
4Buy$11.00+266.67%Reiterates
18 days ago
Nuvation Bio IncNUVB
5Buy$4.50+238.35%Reiterates
18 days ago
Adc Therapeutics SaADCT
11Buy$3.00+194.12%Maintains
20 days ago
Repare Therapeutics IncRPTX
8Buy$25.00+293.70%Reiterates
20 days ago
Allogene Therapeutics IncALLO
7Buy$12.00+385.83%Maintains
25 days ago
Y Mabs Therapeutics IncYMAB
7Buy$11.00+55.37%Reiterates
25 days ago
Effector Therapeutics IncEFTR
2Buy$5.00+863.39%Reiterates
a month ago
Revolution Medicines IncRVMD
10Buy$28.00+13.87%Maintains
a month ago
Aadi Bioscience IncAADI
9Buy$36.00+625.81%Maintains
a month ago
Replimune Group IncREPL
8Buy$48.00+558.44%Maintains
a month ago
Macrogenics IncMGNX
10Buy$12.00+37.77%Maintains
a month ago
Omega Therapeutics IncOMGA
6Buy$12.00+424.02%Maintains
a month ago
Relay Therapeutics IncRLAY
11Buy$19.00+102.77%Maintains
a month ago
Prelude Therapeutics IncPRLD
7Buy$5.00+48.81%Maintains
a month ago
Elicio Therapeutics IncELTX
1Buy$12.00+100.33%Assumes
a month ago
Oric Pharmaceuticals IncORIC
11Buy$16.00+69.67%Maintains
a month ago
Pmv Pharmaceuticals IncPMVP
6Buy$5.00+116.45%Maintains
2 months ago
Apollomics IncAPLM
3Buy$17.00+1,935.93%Maintains
2 months ago
Exelixis IncEXEL
1Buy$28.00+27.27%Initiates Coverage On
2 months ago
Nurix Therapeutics IncNRIX
9Buy$35.00+306.98%Maintains
3 months ago
Cogent Biosciences IncCOGT
3Buy$27.00+212.50%Reiterates
3 months ago
Kineta IncKA
3Buy$8.00+86.48%Reiterates
4 months ago
Kinnate Biopharma IncKNTE
6Buy$24.00+948.03%Reiterates
4 months ago
Zymeworks IncZYME
11Hold$8.00-13.89%Reiterates
4 months ago
Viracta Therapeutics IncVIRX
5Buy$10.00+1,896.01%Reiterates
4 months ago
Tango Therapeutics IncTNGX
4Buy$16.00+74.29%Maintains
4 months ago
Gt Biopharma IncGTBP
6Buy$5.00+2,122.22%Reiterates
4 months ago
Caribou Biosciences IncCRBU
5Buy$23.00+295.87%Maintains
4 months ago
Atara Biotherapeutics IncATRA
5Buy$28.00+4,079.10%Maintains
6 months ago
Ikena Oncology IncIKNA
4Buy$22.00+1,057.89%Reiterates
9 months ago
Fate Therapeutics IncFATE
6Hold$7.00+212.50%Downgrades
a year ago
Tcr2 Therapeutics IncTCRR
4Buy$13.00N/AMaintains
a year ago
Neoleukin Therapeutics IncNLTX
3HoldN/AN/ADowngrades
a year ago
Forma Therapeutics Holdings IncFMTX
2Hold$20.00N/ADowngrades
a year ago
Turning Point Therapeutics IncTPTX
6Hold$76.00N/ADowngrades
2 years ago
Cytomx Therapeutics IncCTMX
1Buy$11.00N/AMaintains
2 years ago
Nucana PLCNCNA
2Buy$9.00N/AMaintains
2 years ago
Molecular Partners AgMOLN
1Buy$25.00N/AAssumes
2 years ago
Autolus Therapeutics PLCAUTL
1Buy$13.00N/AMaintains
3 years ago
Immunomedics IncIMMU
4Hold$88.00N/ADowngrades
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.